electroCore (ECOR) Competitors

electroCore (NASDAQ:ECOR) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, media sentiment, valuation, profitability and community ranking.

Which has more risk & volatility, ECOR or DRTS?

electroCore has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Comparatively, Alpha Tau Medical has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500.

Does the MarketBeat Community favor ECOR or DRTS?

electroCore received 146 more outperform votes than Alpha Tau Medical when rated by MarketBeat users. However, 72.41% of users gave Alpha Tau Medical an outperform vote while only 62.55% of users gave electroCore an outperform vote.

Company	Underperform	Outperform
electroCore	Outperform Votes 167 62.55%	Underperform Votes 100 37.45%
Alpha Tau Medical	Outperform Votes 21 72.41%	Underperform Votes 8 27.59%

Does the media favor ECOR or DRTS?

In the previous week, electroCore had 1 more articles in the media than Alpha Tau Medical. MarketBeat recorded 7 mentions for electroCore and 6 mentions for Alpha Tau Medical. electroCore's average media sentiment score of 0.91 beat Alpha Tau Medical's score of 0.50 indicating that electroCore is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
electroCore	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Alpha Tau Medical	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts recommend ECOR or DRTS?

electroCore currently has a consensus target price of $25.50, indicating a potential upside of 254.41%. Alpha Tau Medical has a consensus target price of $8.00, indicating a potential upside of 204.18%. Given electroCore's higher probable upside, equities research analysts plainly believe electroCore is more favorable than Alpha Tau Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
electroCore	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Alpha Tau Medical	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do insiders and institutionals hold more shares of ECOR or DRTS?

26.7% of electroCore shares are held by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are held by institutional investors. 19.7% of electroCore shares are held by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Is ECOR or DRTS more profitable?

Alpha Tau Medical has a net margin of 0.00% compared to electroCore's net margin of -54.40%. Alpha Tau Medical's return on equity of -38.62% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
electroCore	-54.40%	-154.45%	-69.16%
Alpha Tau Medical	N/A	-38.62%	-29.89%

Which has better earnings & valuation, ECOR or DRTS?

electroCore has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than electroCore, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
electroCore	$25.18M	2.06	-$18.83M	-$1.62	-4.44
Alpha Tau Medical	N/A	N/A	-$29.16M	-$0.45	-5.84

Summary

electroCore beats Alpha Tau Medical on 8 of the 15 factors compared between the two stocks.